Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

ESOC 2021

 

The 7th European Stroke Conference took place virtually, from 1 – 3 September 2021. The conference brought together leading experts to discuss the latest clinical trial results, technological advancements, and their impact on clinical practice.

Explore all the key news below!

Latest videos from ESOC 2021

View all
5:30
Blood biomarkers to guide secondary stroke prevention with anticoagulation
Mira Katan • 8 Sep 2021
4:14
White matter lesions—should all patients receive antihypertensive treatment?
Christopher Chen • 8 Sep 2021
3:21
Promising neurostimulation techniques to promote stroke recovery
Jesse Dawson • 8 Sep 2021
3:23
CSF and PET biomarkers under investigation for CAA
Gargi Banerjee • 3 Sep 2021

Hemorrhagic Stroke News

View all
1:33
Future research needs for intracerebral hemorrhage
Valeria Caso • 31 Aug 2021
2:09
The promise of CSF and PET biomarkers in CAA
Gargi Banerjee • 3 Sep 2021

Ischemic Stroke News

View all
1:48
Expedited recommendation for short-term dual antiplatelet therapy after minor stroke & high-risk TIA
Ana Catarina Fonseca • 6 Sep 2021
1:37
Advances in acute ischemic stroke at ESOC 2021
Joanna Wardlaw • 31 Aug 2021

Latest Treatment Updates

View all
1:44
CHANCE-2: ticagrelor versus clopidogrel in CYP2C19 allele carriers
S. Claiborne Johnston • 7 Sep 2021
3:45
Biomarker-driven trials of anticoagulants vs antiplatelets for secondary stroke prevention
Mira Katan • 8 Sep 2021

Stroke Prevention

View all
3:16
Inflammation as a target for primary and secondary stroke prevention
Ángel Chamorro • 6 Sep 2021
5:04
INSPiRE-TMS – an intensive secondary prevention program
Heinrich Audebert • 27 Aug 2021
The content of VJNeurology is intended for healthcare professionals